Current IVF clinical trials
Since 1986 when we first opened, Boston IVF has conducted ground-breaking research that has contributed to vast improvements in assisted reproductive technologies and fertility treatment. Patients at Boston IVF benefit from working with the experts who conducted these studies; when appropriate, patients are invited to participate in research studies as well. Below are brief descriptions of current or expired trials conducted by Boston IVF. The ISIS and FORTT trials were done in affiliation with Harvard Medical School, Dartmouth College and Beth Israel Deaconess Medical Center (BIDMC) and werefunded by the National Institutes of Health (NIH), the primary agency for conducting medical research.
ISIS STUDY: The purpose of this study is to evaluate the link between lifestyle and fertility. This study is currently recruiting women age 20-34 and their male partners who are planning their first pregnancy. Click here for more information on this trial. Additionally, Boston IVF initiates new research projects on a regular basis. If you are interested in enrolling in a study or learning more about our research, please speak with your Boston IVF physician or our Study Coordinator, Kristin B.
ANTI-MULLERIAN HORMONE (AMH) STUDY
The purpose of the study is to evaluate a new lab test for Anti-Mullerian Hormone (AMH). This is a blood test that may give us information about your fertility. Participants will be asked to have an extra tube of blood drawn on one occasion and share information from their medical record about their health histpry. This will include the results of your ultrasound.
The Patients Voice in HIV/AIDS Clinical Trial Participation: What motivates the willingness of HIV infected people to take part in HIV/AIDS clinical trials?
Book (LAP LAMBERT Academic Publishing)
Call to step up the pace of TB-HIV collaborative activities — Weekly Blitz
Discovery by biomedical research of new and improved interventions can get into the bucket of implementation.